ACTIVE_NOT_RECRUITING

Using Information Technology to Improve Outcomes for Children Living With Cancer

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This proposed study plans to develop and evaluate a patient-oriented, technology-based, symptom monitoring system that reports symptoms experienced by children with cancer to their parents and health care providers.

Official Title

Using Information Technology to Improve Outcomes for Children Living With Cancer

Quick Facts

Study Start:2021-04-01

Study Completion:2025-12-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT04789720

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 17 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD

Inclusion Criteria	Exclusion Criteria
* Have an hematology/oncologic diagnosis (including a brain tumor) * Be on-treatment or within 6 months post-therapy * Be between 8 and 17 years old * English-speaking * Have sufficient cognitive and motor abilities to complete survey via an electronic device (e.g., smartphone, iPAD, etc.) or computer * Be able and willing to sign assent forms (for those 12-17 years old). * Be a parent (father or mother) or a legal guardian of eligible patients * Demonstrates sufficient English and/or Spanish ability to understand and sign the informed consent form * Have sufficient cognitive and motor abilities to complete survey via an electronic device (e.g., smartphone, iPAD, etc) or computer	* Patients who cannot understand English sufficiently to sign consent/assent form * Patients who cannot understand English sufficiently to complete the questionnaires

Inclusion Criteria

Exclusion Criteria

* Have an hematology/oncologic diagnosis (including a brain tumor)
* Be on-treatment or within 6 months post-therapy
* Be between 8 and 17 years old
* English-speaking
* Have sufficient cognitive and motor abilities to complete survey via an electronic device (e.g., smartphone, iPAD, etc.) or computer
* Be able and willing to sign assent forms (for those 12-17 years old).
* Be a parent (father or mother) or a legal guardian of eligible patients
* Demonstrates sufficient English and/or Spanish ability to understand and sign the informed consent form
* Have sufficient cognitive and motor abilities to complete survey via an electronic device (e.g., smartphone, iPAD, etc) or computer

* Patients who cannot understand English sufficiently to sign consent/assent form
* Patients who cannot understand English sufficiently to complete the questionnaires

Contacts and Locations

Principal Investigator

Jin-Shei Lai, PhD

PRINCIPAL_INVESTIGATOR

Northwestern University

Study Locations (Sites)

Ann & Robert H. Lurie Childrens Hospital of Chicago

Chicago, Illinois, 60611

United States

Collaborators and Investigators

Sponsor: Northwestern University

Jin-Shei Lai, PhD, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-04-01

Study Completion Date2025-12-31

Study Record Updates

Study Start Date2021-04-01

Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

children living with cancer

Additional Relevant MeSH Terms

Cancer